Calamos Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,739
Closed -$328K 940
2024
Q2
$328K Buy
+13,739
New +$322K ﹤0.01% 738
2022
Q2
Sell
-106,504
Closed -$3.67M 1158
2022
Q1
$3.67M Sell
106,504
-66,713
-39% -$2.17M 0.01% 796
2021
Q4
$8.62M Buy
173,217
+48,959
+39% +$2.58M 0.03% 548
2021
Q3
$5.72M Buy
+124,258
New +$4.93M 0.03% 571
2021
Q2
Sell
-124,368
Closed -$2.53M 957
2021
Q1
$2.53M Buy
+124,368
New +$2.62M 0.01% 663

Other funds holding ASPN

Calamos Advisors's ASPN Position: Q3 2024 in Review

Calamos Advisors sold out of Aspen Aerogels (ASPN) in Q3 2024, closing a stake of 13,739 shares — an estimated $328K sold.

Calamos Advisors first reported a position in ASPN in Q1 2021 and held it in 5 quarters. The position peaked at $8.62M in Q4 2021. 243 funds tracked by Wall St. Rank hold ASPN as of Q3 2024.

  • Calamos Advisors reported no remaining Aspen Aerogels position as of Q3 2024 after selling out during the quarter.
  • Calamos Advisors sold 13,739 Aspen Aerogels shares in Q3 2024, an estimated $328K.
  • Calamos Advisors first reported a position in Aspen Aerogels in Q1 2021 and held it in 5 quarters.
  • Calamos Advisors's Aspen Aerogels position peaked at $8.62M in Q4 2021.
  • 243 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2024.

Based on Calamos Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.